# Oral Supplementation to Enhance Recovery Pilot Study

> **NCT03204266** · EARLY_PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 46 (actual)

## Conditions studied

- Malignant Neoplasms of Urinary Tract

## Interventions

- **DRUG:** Arginine recovery supplement
- **DIETARY_SUPPLEMENT:** Omega-3 Fatty Acids

## Key facts

- **NCT ID:** NCT03204266
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-16
- **Primary completion:** 2022-05-25
- **Final completion:** 2022-05-25
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2022-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03204266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03204266, "Oral Supplementation to Enhance Recovery Pilot Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03204266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*